1/3-Community Psychosis Risk Screening: An Instrument Development Study Supplement

1/3-社区精神病风险筛查:工具开发研究补充

基本信息

  • 批准号:
    9675623
  • 负责人:
  • 金额:
    $ 5.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Abstract of the Study “Community psychosis risk screening: An instrument development study” The ongoing, funded parent study aims to develop a brief, valid screening questionnaire to identify individuals at risk for psychosis in non-clinical populations across 3 large, community catchment areas with diverse populations. This is a needed study, as the current screening tools for at-risk psychotic populations have been validated only in clinical and/or treatment seeking samples, which are not likely to generalize beyond these specialized settings. This project is administering 3 well-known psychosis risk screeners, as well as symptom- based (e.g., depression, anxiety, etc.) and risk-factor based questionnaires (e.g., cannabis and other substance use, a family history of major mental disorders, trauma history) to 12,000 adolescents/young adults in local communities across 3 demographically diverse sites (the greater Philadelphia, Baltimore, and Chicago areas, including neighboring rural/suburban areas). Based on established cut-off scores from the 3 psychosis screeners, 2,000 subjects deemed as questionnaire higher risk (QHR; n=1,000) and questionnaire lower risk (QLR; n=1,000) for psychosis (estimated sample sizes based on pilot data and anticipated loss to follow up) will be invited to complete semi-structured interviews to determine clinical high risk (CHR) for psychosis status based on the Structured Interview for Psychosis-Risk Syndromes (SIPS) and to assess current/past major mental disorders based on the Structured Clinical Interview for DSM-5 (SCID-5). The SIPS psychosis-risk persistence syndromes and the DSM-5 attenuated positive syndrome (both assessed with the SIPS 5.6) also will be collected and will be examined in supplementary analyses. Based on preliminary data and conservative estimates, we anticipate that 186 of the QHR group will be considered CHR for psychosis. The specific aims are as follows: 1) to determine norms and prevalence rates of attenuated positive psychotic symptoms across 3 diverse, community catchment areas and 2) to develop a screening questionnaire, inclusive of both symptom-based and risk factor-based questions, that is validated against the SIPS to identify those at CHR for psychosis in the community. This is the first study in the U.S. to determine the rate of subthreshold psychotic symptoms across diverse non-help seeking samples, which is essential for any investigation that uses dimensional approaches to psychotic disorders. Further, this study will develop an essential screening tool that will identify which individuals have the greatest need of follow-up with structured interviews in CHR studies or clinical settings to determine psychosis-risk status. This tool is will be valuable given findings that those who develop psychotic disorders often do not seek treatment until after the onset of the disorder, and that duration of untreated psychosis is associated with more serious clinical outcomes. The funded study has the potential for major contributions to the early detection and prevention of psychotic disorders.The proposed diversity supplement will fit within this award by providing essential training and time for a predoctoral student, Arielle Ered, to develop her program of investigating neural and psychosocial risk factors for psychosis.
“社区精神病风险筛查:一种工具开发研究”研究摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAUREN M ELLMAN其他文献

LAUREN M ELLMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAUREN M ELLMAN', 18)}}的其他基金

CAPER: Computerized Assessment of Psychosis Risk Supplement
CAPER:精神病风险补充的计算机化评估
  • 批准号:
    10540475
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
CAPER: Computerized Assessment of Psychosis Risk
CAPER:精神病风险的计算机化评估
  • 批准号:
    10361304
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
CAPER: Computerized Assessment of Psychosis Risk
CAPER:精神病风险的计算机化评估
  • 批准号:
    10794659
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
CAPER: Computerized Assessment of Psychosis Risk
CAPER:精神病风险的计算机化评估
  • 批准号:
    10569011
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
CAPER: Computerized Assessment of Psychosis Risk
CAPER:精神病风险的计算机化评估
  • 批准号:
    9980111
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
Maternal Inflammation During Pregnancy: Clinical and Neurocognitive Outcomes in Adult Offspring
怀孕期间母体炎症:成年后代的临床和神经认知结果
  • 批准号:
    10600865
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
Maternal Inflammation During Pregnancy: Clinical and Neurocognitive Outcomes in Adult Offspring
怀孕期间母体炎症:成年后代的临床和神经认知结果
  • 批准号:
    10380812
  • 财政年份:
    2019
  • 资助金额:
    $ 5.23万
  • 项目类别:
1/3 Community Psychosis Risk Screening: An Instrument Development Study
1/3 社区精神病风险筛查:仪器开发研究
  • 批准号:
    10203788
  • 财政年份:
    2017
  • 资助金额:
    $ 5.23万
  • 项目类别:
Fetal exposure to maternal stress and inflammation: Effects on neurodevelopment
胎儿暴露于母体压力和炎症:对神经发育的影响
  • 批准号:
    8297405
  • 财政年份:
    2012
  • 资助金额:
    $ 5.23万
  • 项目类别:
Fetal exposure to maternal stress and inflammation: Effects on neurodevelopment
胎儿暴露于母体压力和炎症:对神经发育的影响
  • 批准号:
    8596852
  • 财政年份:
    2012
  • 资助金额:
    $ 5.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了